Erythrocyte blood group systems may be cited as representative prototypes of genetic markers, that have been studied extensively. The human leukocyte antigen (HLA) system, which is now studied with keen interest, is developing into one of the most important genetic markers. Both the blood groups and the HLA constitute critical factors for the success of blood transfusion and tissue transplantation. However, the majority of genetic markers, with exception of blood groups and HLA, are enzymes or other proteins of tissues and blood plasma which were discovered and identified largely by the development of electrophoretic and chromatographic techniques. They are highly evaluated tools for the recognition of human individuality and the study of human polymorphisms.
Recently, genetic polymorphisms were detected by electrophoretic methods in a number of human complement proteins: C2, C3, C4, C5, C6, C7, C8, Factor B(BF), Factor D and Cl-inhibitor (See Alper and Rosen, 1976; Lachmann and Hobart, 1978; and Hobart et al., 1981 for C5 polymorphism) . Some of these polymorphisms attracted special attention of investigators because of the discovery of associations between particular alleles and disseases, such as those between C3*F and rheumatoid arthritis (Farhud et al., 1972) or BF*F1 and the early-onset insulindependent diabetes mellitus (IDDM) (Raum et al., 1979; Kirk et al., 1979) on the one hand, and because of the linkage between C2, C4 and BF loci and the MHC loci on the short arm of the chromosome No. 6, on the other. Thus far, most studies have been confined to the European racial groups. In this review, we present the data mainly obtained in our laboratory concerning the polymorphisms of BF and C2 in Japanese with special reference to the distribution of the variant types, linkage disequilibrium with alleles of HLA loci, and some evidences of disease associations. Also the present status of typing of C3 and C4 in Japan is briefly mentioned.
C3 polymorphism
Using flesh sera, this polymorphism is easily shown by protein stain after agarose gel electrophoresis. It is known that a "fast" variant of C3 has an appreciable frequency in Japanese: 12 out of 464 samples (Tokyo) in one study (Harada et al., 1975) and 9 out of 1,092 samples (Kyoto) in another study (Nishimukai et al., 1979) were found to be heterozygous for this variant. In our preliminary study (Tokyo), 8 samples among 525 were found to be heterozygous for a fast C3 variant. It is likely that this variant is not identical to the C3 F variant commonly found in Europeans. We recently examined C3 types of sera from 113 patients with rheumatoid arthritis and found no evidence for an elevated incidence of the variant C3 types (unpublished).
Factor B (BF) polymorphism
BF polymorphism is usually examined by an agarose gel electrophoresis followed by immunofixation (Alper etal., 1972) . In addition to a pair of common alleles (BF*F and BF*S), two relatively uncommon alleles BF*F1 and BF*SO.7 are Kirk et al., 1979) . Horai (1976) was the first to report BF allele frequency in Japanese, but no variant phenotype other than the three common phenotypes (S, SF and F) were found among 360 healthy donors in Nara Prefecture. Recently, we detected a BF variant similar but not identical to BF F1 type (Tokunaga et al., 1981a) . It migrates slightly slower than BF F1 and the conversion product Bb after zymosan treatment shows a distinct band (Fig. 1) . The variant allele was denoted BF*FT (F Tokyo) 9 In a sample from 65 IDDM patients of Tokyo Women's Medical College, two samples were found to be heterozygous for this variant: one BF FFT and the other BF SFT. In a control sample of 491 unrelated healthy individuals, the variant was encountered only once. Thus, the incidence of the BF FT positive phenotypes was shown to be significantly elevated in IDDM patient group (p<0.05) (Tokunaga (Table 2 ). It is interesting that association of a rare BF variant and I D D M is found in different racial groups (Southern European and Japanese) but the variant BF alleles involved in this association are not identical between two racial groups. BF typing was also carried out in a sample from 123 patients of rheumatoid arthritis. BF FTS phenotype was observed once, showing no statistically significant increase of the variant. Fig, 2 . Photograph showing the isoelectrofocusing patterns of various C2 phenotypes found in Japanese (Tokunaga et al., 1981b) . Note that the bands corresponding to C2 AT show relatively more intense hemolytic activity.
We also studied associations between BF alleles and allele of HLA A, HLA B and HLA C (Tokunaga et al., 1982) . The following associations were found to have significantly positive delta values and considered to be in linkage disequilibrium: 
C2 polymorphism
Polymorphism of C2 was detected in our laboratory by isoelectrofocusing (pH 5-7 or 5-8) in polyacrylamide gel followed by visualization of C2 hemolytic bands with sensitized sheep erythrocytes in agarose overlay.
Relatively few studies on the distribution of C2 polymorphic types have been reported (Table 3 ). In Japanese, at least four alleles at the C2 locus seem to occur: C2"C, C2*B, C2*AT and C2*A' (Fig. 2 and Table 4 ). C2*AT and C2*A' are the variants not hitherto known in European populations (Tokunaga et al., 1981b) . The results of simultaneous typing of HLA-A, -B, and -C specificities indicated the presence of significant associations of C2*AT with HLA-B15 (p<0.0001) and with HLA-A26 (p<0.01), and of C2*B with HLA-Bw61 (p<0.025). None of these allelic combinations seem to be in linkage disequilibrium in European populations, in contrast to the fact that some allelic combinations between BF and HLA-B indicated linkage disequilibrium common to both European and Japanese populations. This finding may suggest that the BF locus is more closely linked to HLA-B locus than the C2 locus.
No difference in the C2 phenotypic distribution was observed between samples a "A" refers to the "acidic" variants. Table 4 . Distribution of C2 phenotypes and allele frequencies in Japanese (Tokunaga et al., 1981b of IDDM patients and controls. However, in an investigation of C2 types in 120 samples of rheumatoid arthritis patients, a statistically significant deficit of C2 AT positive phenotype was observed (p<0.025) (unpublished data). In this respect, it is interesting that the C2 AT positive phenotype seems to have an increased C2 hemolytic activity compared to those of other phenotypes (Tokunaga et al., 1981b). There are three theoretical possibilities for an association between the variant complement allele and the particular disease: 1) dysfunction of the variant complement protein, 2) linkage disequilibrium with disease susceptibility gene(s) in MHC region, and 3) epistatic effects. The first possibility seems to be preferred in the recent review by Rittner and Bertrams (1981) . At present, however, there seems to be no positive evidence for one of these possibilities so far as the electrophoretic variant of the human complement is concerned. Tokunaga et al. (1979) reported the population data of C4 polymorphism in Japanese following the two allele model. In view of the rapidly increasing literatures supporting the more recent two locus model of C4 first proposed by O'Neill et al. (1978) , it seems to be premature to use this system as an established genetic marker.
C4 polymorphism
In concluding, two polymorphic systems of the complement, BF and C2, are of particular importance at present as genetic markers for studies of linkage with HLA loci, disease associations and population genetics in Japanese.
